Clinical Trial Update: Paclitaxel and Intraperitoneal Carboplatin Followed by Radiation Therapy in Treating Patients With Stage IIIC-IV Uterine Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating paclitaxel and intraperitoneal carboplatin followed by radiation therapy in advanced uterine cancer was terminated; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Serous Adenocarcinoma
• Stage Iiia Uterine Cancer
• Stage Iiib Uterine Cancer
• Stage Iiic Uterine Cancer
• Stage Iiic1 Uterine Cancer
• Stage Iiic2 Uterine Cancer
• Stage Iva Uterine Cancer
• Stage Ivb Uterine Cancer
• Uterine Corpus Cancer

Drugs mentioned

• Carboplatin (intraperitoneal) (carboplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Albert Einstein College of Medicine | Conditions: Endometrial Serous Adenocarcinoma, Stage IIIA Uterine Corpus Cancer | Phase 2 | Status: TERMINATED | Results posted: 2023-08-29